CSL Ltd

Products

Full Paper

Full Paper

Price: £95.00
Description: The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.



Research Report Overview

Published Date: 21/02/2012
Category: Therapies & Markets

Research Report Decription

CSL Ltd - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

  • Provides all the crucial information on CSL Limited required for business and competitor intelligence needs
  • Contains a study of the major internal and external factors affecting CSL Limited in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of CSL Limited
  • Data is supplemented with details on CSL Limited history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from CSL Limitedata and key trends

Key Questions Answered:

  •  Support sales activities by understanding your customers’ businesses better
  • Understand prospective partners and suppliers
  • Keep fully up to date on your competitors’ business structure, strategy and prospects
  • Obtain the most up to date company information availableture, strategy and prospects

Companies Mentioned:

CSL ltd

Paper Highlights:

CSL Limited (CSL) is a biopharmaceutical group engaged in the R&D, manufacture, marketing and distribution of biopharmaceutical and allied products. CSL invests in the development of protein-based medicines for treating serious human diseases. The group operates globally through its human health businesses that include the operations of CSL Behring, CSL Bioplasma and CSL Biotherapies. CSL is headquartered in Victoria, Australia and employed about 10,000 people as of June 30, 2011.  The group recorded revenues* of A$4,321.6 million (approximately $4,277.9 million) during the financial year ended June 2011 (FY2011), a decrease of 6.6% compared with FY2010. The operating profit of the group was A$1,212.6 million (approximately $1,200.4 million) during FY2011, a decrease of 13.2% compared with FY2010. The net profit was A$940.6 million (approximately $931.1 million) in FY2011, a decrease of 10.7% compared with FY2010.  * Total revenues = sales revenues+ other revenues + other income